Corticosteroids in preventing severe lupus flares: do all patients have the same risk? Comment on the article by Tseng et al.
Callejas-Rubio
José Luis
JL
Rios-Fernández
Raquel
R
Tomás-Jiménez
Cristina
C
Ortego-Centeno
Norberto
N
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology; D018501:Antirheumatic Agents / Q000627:therapeutic use; D004247:DNA / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D012307:Risk Factors
D000305:Adrenal Cortex Hormones; D000888:Antibodies, Anti-Idiotypic; D018501:Antirheumatic Agents; D006886:Hydroxychloroquine; D004247:DNA; D011241:Prednisone